Trial
NCT03121677
Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
—
Condition
Follicular Lymphoma
Intervention
Personalized tumor vaccine
Why stopped
Vaccine manufacturing has been suspended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-14